Pure Global Cannabis Inc.

OTC: PRCNF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#1161 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 23

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, listing tenure · ↓ market scale, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$17.1M

Employees

—

as of 2026-08-04

Market cap

$1.6k

as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02018

Net income-$17.1M-$17.1M2018

Operating income-$5.9M-$5.9M2018

Total assets$16.3M$16.3M2018

Liabilities$9.6M$9.6M2018

Equity$6.7M$6.7M2018

Revenue trend

FY2015 – FY2018 · USD

FY15

FY16

FY17

FY18

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Pure Global Cannabis Inc.’s revenue?

Pure Global Cannabis Inc. booked $0 in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Dermisonics, Inc.——Isracann Biosciences Inc.——Legacy Technology Holdings, Inc.——Aamaxan Transport Group, Inc.——Xcorporeal, Inc.——Speakeasy Cannabis Club Ltd.——

Key facts

CEOMalay Panchal

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: PRCNF

Employees—

IPO date2018-07-17

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.